BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(16 sites)
Denmark
Aarhus Universitetshospital, Aarhus Rigshospitalet, Copenhagen Norway
Oslo University Hospital, Oslo Sweden
Östersund Sjukhus, Östersund, Jämtland Härjedalen Region Jönköpings Län, Jönköping, Region Jönköping Last updated December 2024